Formulation mattersBack in February 2017, CDMO Rentschler Biopharma SE and formulation specialist Leukocare AG joined forces to give biologics and biosimilar makers a competitive edge through significantly stabilised end … more ➔
Turning cancer into a chronic diseaseFollowing last years approval by the US FDA, the EUs EMA has now also approved the first two T-cell-based immunotherapies against certain types of cancer. This marks the ultimate proof-of-concept … more ➔
Skilful asset swapping in the time of big...Independent investment analyst, Managing Director EQUI.TS GmbH_ Big data analytics is poised to change the way business is done in the life sciences. A string of recent M&A transactions illustrate … more ➔
Single-use plastics: New EU rules to reduc... Plastics are magical materials, and they will be even more important in the future than they are today. But they lead to microplastics in the environment, especially noticeable as marine littering. … more ➔
Balancing generic and innovative medical u...Is cheaper always better when it comes to generics? What about when it comes to innovative medical uses of them? more ➔
Merging industriesIn mid-November, the European Commission tabled the long-awaited review of its Bioeconomy Strategy and Action Plan. European Biotechnology spoke with Waldemar Kütt, Head of Unit Bioeconomy Strategy, … more ➔
pharma labelling, pharmaceutical packaging, tamper-resistant Connectivity is the futurePharmaPack 2018:?The promises of digitalised medicine dont stop at injection pens or autoinjectors. One of the early adopters in the field is Swiss Haselmeier AG (Pharmapack: hall 7.1, booth L19). … more ➔
Biotech enabling Europe to reach UN SDGsThe UN Sustainable Development Goals (SDGs) provide a powerful blueprint for coordinating global efforts to end poverty through economic growth, reducing inequality, and providing better education, health, … more ➔
